203 filings
Page 6 of 11
8-K
6ydb8appaw2oliet62ha
4 Mar 21
Regulation FD Disclosure
4:29pm
8-K
4bdpcbx2ylib2e
4 Mar 21
Evofem Biosciences Reports Fourth Quarter and Year-End 2020
4:00pm
8-K
4kq9djef 272t4e1
22 Feb 21
Regulation FD Disclosure
6:12am
8-K
oz6li0fi9nj2qrkf0
5 Feb 21
Regulation FD Disclosure
8:02am
8-K
9uqxcckaia6ecx
1 Dec 20
Regulation FD Disclosure
4:05pm
8-K
xnd1oq rfa9xyzob6
18 Nov 20
Regulation FD Disclosure
5:04pm
8-K
ya7apaz fi
9 Nov 20
Evofem Biosciences Reports Third Quarter 2020
4:04pm
8-K
ib8iuj
15 Oct 20
Evofem Biosciences Secures $25 Million
8:05am
8-K
elcneu4u t6m2b
14 Sep 20
Regulation FD Disclosure
3:21pm
8-K
ahvo0wtt
4 Aug 20
Evofem Biosciences Reports Second Quarter 2020
8:01am
8-K
vb8s9 h66svg5qxffa1e
18 Jun 20
Submission of Matters to a Vote of Security Holders
4:24pm
8-K
glir2
9 Jun 20
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
5:09pm
8-K
01hq8y0maiz
3 Jun 20
Other Events
4:52pm
8-K
kshgtq
2 Jun 20
Termination of a Material Definitive Agreement
4:21pm
8-K
ya0il o9h
22 May 20
Other Events
4:05pm
8-K
unj10 f10yt2
12 May 20
Departure of Directors or Certain Officers
4:11pm
8-K
zcbvz9k x403
6 May 20
Evofem Biosciences Reports First Quarter 2020 Financial Results
8:01am
8-K
pza45wg8jbfj
28 Apr 20
Evofem Biosciences to Report First Quarter 2020 Results and Update on Financing and Commercial Launch Plans
7:59am
8-K
sa7a3wuto k5n
27 Apr 20
Evofem Biosciences Secures up to $25 Million in Convertible Note Financing
8:00am
8-K
otwvo0
17 Apr 20
Entry into a Material Definitive Agreement
4:17pm